Yu M, Undergraduate CC, Gong Y, Md TT, et al. Efficacy and Safety of Aumolertinib/Icotinib Combination Therapy for Naive
EGFR-Mutant NSCLC Patients with Brain Metastases: A Phase I/II Study. Neuro Oncol 2026 Feb 23:noag036. doi: 10.1093.
PMID: 41729955
|